Skip to main content
OpenTrials
Completed

NCT Number: NCT07831629

Clinical and Hemodynamic Correlates of Different Polarities of HD-tDCS in COPD

The aim of this pilot randomized clinical trial is to identify the acute effects of HD-tDCS in the diaphragm cortex on cerebral hemodynamics in individuals with COPD.

The main questions to answer are:

Is there a change in cortical metabolism (HbO and OXYHb consumption) during and immediately after the application of HD-tDCS? Are there any particularities in cortical hemodynamics between the different HD-tDCS polarities? Participants will perform three HD-tDCS sessions, each one with a different type of stimulation (anodal, cathodal and sham) lasting for 20 minutes. Before, during and after stimulation, near-infrared spectrography will be used as assessment instruments.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aging and Neuroscience Studies Laboratory

João Pessoa, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age over 18 years old;
  • Airflow limitation mild to severe (GOLD 1-3);
  • No contraindications for HD-tDCS, such as pregnancy, metal implants in the head, cochlear implants and pacemaker;
  • Absence of concomitant diseases of the central or peripheral nervous system.

Exclusion criteria

  • Refusal to sign the TCLE;
  • Missing two consecutive or three alternate sessions during treatment;
  • Develop any disabling condition that prevents continued participation in the study.

Treatment and study plan

high-definition transcranial direct current stimulation

Device

Participants will receive stimulation through electrode positioning according to the International 10-20 System. The central electrode will be placed over the left diaphragm cortex, accompanied by four return electrodes. The current will be administered using a 3mA protocol for 20 minutes, with a 30-second ramp-up at the beginning and a 30-second ramp-down at the end of the stimulation for active groups. For the placebo group, the setup will remain identical; however, regarding the protocol, the device initially reaches a current of 3 mA and then drops to 0.1 mA within the first 30 seconds, remaining at this current for 20 minutes. A current of 3 mA will be reinstated only in the final 30 seconds, once again accompanied by ramp-up and ramp-down phases.

Other names: HD-tDCS

Sham High-definition Transcranial Direct Current Stimulation

Other

Participants received sham stimulation using the same electrode positioning as the active conditions (International 10-20 System), with a central electrode over the left diaphragm cortex and four return electrodes. The device initially reached a current of 3 mA and then dropped to 0.1 mA within the first 30 seconds, remaining at this current for 20 minutes. A current of 3 mA was reinstated only in the final 30 seconds, accompanied by ramp-up and ramp-down phases, replicating the initial and final sensations of active stimulation without delivering a sustained therapeutic current.

Other names: Sham HD-tDCS

Primary outcomes

  1. Change in cerebral hemodynamic response

    Time frame: Before, during, and after each 20-minute HD-tDCS session

    Change in oxygenated (OxyHb) and deoxygenated (DeoxyHb) hemoglobin concentration measured by functional near-infrared spectroscopy (fNIRS)

Secondary outcomes

  1. respiratory muscle strength

    Time frame: Immediately before and immediately after the intervention

    Maximum inspiratory and expiratory pressure values, recorded using manovacuometry.

Sponsors and collaborators

Lead sponsor

Federal University of Paraíba

Other

Registry information

Official study title

Clinical and Hemodynamic Correlates of Different Polarities of High-definition Transcranial Direct Current Stimulation in Chronic Respiratory Disease

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Sep 21, 2026
Registry last updated
Sep 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.